| Literature DB >> 32015437 |
Aaron A Smargon1, Yilan J Shi1,2, Gene W Yeo3,4.
Abstract
Deployment of RNA-guided DNA endonuclease CRISPR-Cas technology has led to radical advances in biology. As the functional diversity of CRISPR-Cas and parallel systems is further explored, RNA manipulation is emerging as a powerful mode of CRISPR-based engineering. In this Perspective, we chart progress in the RNA-targeting CRISPR-Cas (RCas) field and illustrate how continuing evolution in scientific discovery translates into applications for RNA biology and insights into mysteries, obstacles, and alternative technologies that lie ahead.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32015437 PMCID: PMC8008746 DOI: 10.1038/s41556-019-0454-7
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824